FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * ACCBT Corp.   2. Issuer Name and Ticker or Trading Symbol BRAINSTORM CELL THERAPEUTICS INC [BCLI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) MORGAN AND MORGAN BUILDING, PASEA ESTATE, ROAD TOWN 3. Date of Earliest Transaction (Month/Day/Year) 08/09/2007 (Street) TORTOLA, D8  4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/09/2007   P   8,500 A $ 1.0247 7,075,000 D   Common Stock 08/09/2007   P   66,500 A $ 1.01 7,075,000 D   Common Stock 08/10/2007   P   13,500 A $ 1 7,075,000 D   Common Stock 08/10/2007   P   20,500 A $ 0.9663 7,075,000 D   Common Stock 08/13/2007   P   16,000 A $ 1.05 7,075,000 D   Common Stock 08/13/2007   P   29,500 A $ 1.0491 7,075,000 D   Common Stock 08/14/2007   P   20,500 A $ 1.0797 7,075,000 D   Common Stock 08/15/2007   P   20,500 A $ 1.0597 7,075,000 D   Common Stock 08/15/2007   P   4,500 A $ 1.07 7,075,000 D   Common Stock 08/10/2007   M   6,875,000 A $ 0.1818 (1) 7,075,000 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrant to Purchase Common Stock

$ 0.2

08/10/2007

M

7,562,500

08/10/2007

11/05/2011

Common Stock

7,562,500

$ 0

7,562,500

D

Right to Acquire Common Stock

$ 0.1818

08/10/2007

M

6,875,000

07/02/2007

(2)

Common Stock

27,500,000

$ 0

20,625,000

D

Right to Acquire Warrant to Purchase Common Stock

$ 0

08/10/2007

M

7,562,500

07/02/2007

(2)

Common Stock

30,250,000

$ 0

22,687,500

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
ACCBT Corp. MORGAN AND MORGAN BUILDING PASEA ESTATE, ROAD TOWN TORTOLA, D8		X

Signatures

/s/ Thomas B. Rosedale (Pursuant to Power of Attorney)		08/17/2007
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The reporting person acquired the shares of Common Stock pursuant to that certain Subscription Agreement (the "Subscription Agreement"), dated as of July 2, 2007, between the reporting person and Brainstorm Cell Therapeutics Inc. ("Brainstorm"). The aggregate purchase price for the shares of Common Stock was $1,250,000, of which $1,000,000 was paid in cash by the reporting person to Brainstorm and $250,000 was paid by the application of the outstanding principal amount owed by Brainstorm to the reporting person pursuant to that certain 8% Convertible Promissory Note, dated May 6, 2007, in the principal amount of $250,000 issued by Brainstorm to the reporting person.
(2)	There is no expiration date with respect to the reporting person's right to acquire the shares of Common Stock and Warrants to purchase Common Stock pursuant to the Subcription Agreement.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.